A High Level of Intestinal Alkaline Phosphatase Is Protective Against Type 2 Diabetes Mellitus Irrespective of Obesity

EBioMedicine

Volumn 2, Issue 12, 2015, Pages 2016-2023

  Malo, Madhu S ^a,b,c  

^a Atoxin Biotech   (United States)

^b Harvard Biotech BD Ltd   (Bangladesh)

^c MH Samorita Medical College   (Bangladesh)

Author keywords

Fatty liver; Glucose intolerance; Hypertension; Incipient diabetes; Insulin resistance; Obesity; The metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FECES ANALYSIS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; DEFICIENCY; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; ENZYMOLOGY; FECES; INTESTINE; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; ALKALINE PHOSPHATASE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; FECES; FEMALE; HUMANS; INTESTINES; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 84958886589     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.11.027     Document Type: Article

References (44)

1. Abdullah N., Attia J., Oldmeadow C., Scott R.J., Holliday E.G. The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings. Int. J. Endocrinol. 2014, 2014:593982.
2. Alam S.N., Yammine H., Moaven O., et al. Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens. Ann. Surg. 2014, 259:715-722.
3. Al-Qahtani D.A., Imtiaz M.L. Prevalence of metabolic syndrome in Saudi adult soldiers. Saudi Med. J. 2005, 26:1360-1366.
4. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl. 1):S81-S90.
5. Basit A., Shera A.S. Prevalence of metabolic syndrome in Pakistan. Metab. Syndr. Relat. Disord. 2008, 6:171-175.
6. Bentala H., Verweij W.R., Huizinga-Van der Vlag A., van Loenen-Weemaes A.M., Meijer D.K., Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 2002, 18:561-566.
7. Buchet R., Millán J.L., Magne D. Multisystemic functions of alkaline phosphatases. Methods Mol. Biol. 2013, 1053:27-51.
8. Cani P.D., Amar J., Iglesias M.A., Poggi M., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
9. Chen K.T., Malo M.S., Moss A.K., et al. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G467-G475.
10. D'Aversa, et al. Gut microbiota and metabolic syndrome. Intern. Emerg. Med. 2013, 8(Suppl. 1):S11-S15.
11. Ebrahimi F., Malo M.S., Alam S.N., et al. Local peritoneal irrigation with intestinal alkaline phosphatase is protective against peritonitis in mice. J. Gastrointest. Surg. 2011, 15:860-869.
12. Eliakim R., Mahmood A., Alpers D.H. Rat intestinal alkaline phosphatase secretion into lumen and serum is coordinately regulated. Biochim. Biophys. Acta 1991, 1091:1-8.
13. Estaki M., DeCoffe D., Gibson D.L. Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity. World J. Gastroenterol. 2014, 20:15650-15656.
14. Ghosh S.S., Gehr T.W., Ghosh S. Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules 2014, 19:20139-20156.
15. Hamarneh S.R., Mohamed M.M., Economopoulos K.P., et al. A novel approach to maintain gut mucosal integrity using an oral enzyme supplement. Ann. Surg. 2015, 260:706-714.
16. Huang P.L. A comprehensive definition for metabolic syndrome. Dis. Model. Mech. 2009, 2:231-237.
17. Kahn S.E., Cooper M.E., Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 2014, 383:1068-1083.
18. Kaliannan K., Hamarneh S.R., Economopoulos K.P., et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:7003-7008.
19. Kaliannan K., Wang B., Li X.Y., et al. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci. Report. 2015, 5:11276.
20. Kim M.K., Baek K.H., Kang M.I., et al. Serum alkaline phosphatase, body composition, and risk of metabolic syndrome in middle-aged Korean. Endocr. J. 2013, 60:321-328.
21. Lallès J.P. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr. Rev. 2010, 68:323-332.
22. Lalles J.P. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr. Rev. 2014, 72:82-94.
23. Lukas M., Drastich P., Konecny M., et al. Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm. Bowel Dis. 2010, 16:1180-1186.
24. Mahmood A., Shao J.S., Alpers D.H. Rat enterocytes secrete SLPs containing alkaline phosphatase and cubilin in response to corn oil feeding. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G433-G341.
25. Malo M.S., Alam S.N., Mostafa G., et al. Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 2010, 59:1476-1484.
26. Malo M.S., Moaven O., Muhammad N., et al. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306:G826-G838.
27. Malo M.S., Mozumder M., Zhang X.B., et al. Intestinal alkaline phosphatase gene expression is activated by ZBP-89. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G737-G746.
28. Malo M.S., Zhang W., Alkhoury F., et al. Thyroid hormone positively regulates the enterocyte differentiation marker intestinal alkaline phosphatase gene via an atypical response element. Mol. Endocrinol. 2004, 18:1941-1962.
29. Masters S.L., Latz E., O'Neill L.A. The inflammasome in atherosclerosis and type 2 diabetes. Sci. Transl. Med. 2011, 3:81ps17.
30. Matsushita M., Irino T., Kawaguchi T., Komoda T. The effect of different buffers and amounts of intestinal alkaline phosphatase isoforms on total alkaline phosphatase activity. Clin. Chim. Acta 2002, 319:49-55.
31. Meng S., Wu J.T., Archer S.Y., Hodin R.A. Short-chain fatty acids and thyroid hormone interact in regulating enterocyte gene transcription. Surgery 1999, 126:293-298.
32. Moss A.K., Hamarneh S.R., Mohamed M.M., et al. Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304:G597-G604.
33. Narisawa S., Huang L., Iwasaki A., Hasegawa H., Alpers D.H., Millan J.L. Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol. Cell. Biol. 2003, 23:7525-7530.
34. Parekh P.J., Balart L.A., Johnson D.A. The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease. Clin. Transl. Gastroenterol. 2015, 18:6.
35. Ramasamy S., Nguyen D.D., Eston M.A., et al. Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm. Bowel Dis. 2011, 17:532-542.
36. Sergienko E., Su Y., Chan X., Brown B., et al. Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action. J. Biomol. Screen. 2009, 14:824-837.
37. Sharma U., Pal D., Prasad R. Alkaline phosphatase: an overview. Indian J. Clin. Biochem. 2014, 29:269-278.
38. Steinberger J. Diagnosis of the metabolic syndrome in children. Curr. Opin. Lipidol. 2003, 14:555-559.
39. Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
40. Tilg H., Moschen A.R. Microbiota and diabetes: an evolving relationship. Gut 2014, 63:1513-1521.
41. Vaishnava S., Hooper L.V. Alkaline phosphatase: keeping the peace at the gut epithelial surface. Cell Host Microbe 2007, 2:365-367.
42. van Veen S.Q., van Vliet A.K., Wulferink M., Brands R., Boermeester M.A., van Gulik T.M. Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice. Infect. Immun. 2005, 73:4309-4314.
43. Velloso L.A., Eizirik D.L., Cnop M. Type 2 diabetes mellitus-an autoimmune disease?. Nat. Rev. Endocrinol. 2013, 9:750-755.
44. Whitehouse J.S., Riggle K.M., Purpi D.P., et al. The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis. J. Surg. Res. 2010, 163:79-85.